Atlas Trials

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Clinical trial NCT01776554 · COMPLETED

Trial details

NCT number
NCT01776554
Sponsor
Novartis Vaccines
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pandemic H5N1 Influenza
Start date
2013-01-01
Primary completion
2013-06-01
Enrollment
662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.